Some good, some bad and clearly some showing awareness that the pandemic has changed some rules of the (copyright) game Group B highlighted the need for remuneration of creators as well as the importance of measures at the national level.… Continue Reading
Discussions, or rather statements on limitations and exceptions started with the WIPO Secretariat’s report on regional seminars and an international conference that took place in 2019. See Documents: Report on Regional Seminars and International Conference (SCCR/40/2) (available in six languages);… Continue Reading
Today, the hybrid (virtual and @WIPO)Standing Committee on Copyright and Related Rights meeting went more smoothly than yesterday. The tech was checked and tested before the meeting and except for a few statements (some visual or audio failures) we heard… Continue Reading
17 November 2020 Oral statement of Knowledge Ecology International – agenda item 5 – Protection of broadcasting organizations. New measures to address signal theft are one thing. But durable post-fixation rights to entities that just retransmit works by authors, performers… Continue Reading
The WIPO Standing Committee on Copyright and Related Rights is meeting (not as usual) from 12 to 14:30(CET) everyday this week. Day 1 has not gone smoothly because of technological challenges and the Secretariat eventually decided to stop the meeting.… Continue Reading
On November 6, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the, “Prospective Grant of an Exclusive Patent License: Development of a Direct Ocular Administered Formulation of Metformin for Use in Therapeutic Treatment… Continue Reading
One of the characteristics we have seen in our analysis of COVID-19 contracts is heterogeneity. The Bayh-Dole was enacted in 1980 to provide for uniform provisions on funding agreements regarding the ownership of inventions and the public’s rights. But for… Continue Reading
KEI is an accredited non-state actor at the World Health Organization (WHO). This was the oral statement we delivered during the resumed session of the WHA 73 in November 2020. Our statement focused on agenda item 11.9 – Global strategy… Continue Reading
On November 7, 2020, the Department of Health and Human Services (HHS) posted another COVID-19 vaccine contract: the $1 billion agreement between Janssen Pharmaceutical (a component of Johnson & Johnson (“J&J”)) and the U.S. government (through an intermediary called Advanced… Continue Reading
The resumed session of the 73rd session of the World Health Assembly (WHA) meets this week from 9 November 2020 to 14 November 2020. As the Republic and Canton of Geneva has imposed a lockdown since 2 November 2020, the… Continue Reading